Cargando…

The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target

Thioredoxin interacting protein (TXNIP) is a metabolism- oxidative- and inflammation-related marker induced in cardiovascular diseases and is believed to represent a possible link between metabolism and cellular redox status. TXNIP is a potential biomarker in cardiovascular and ischemic diseases but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domingues, Alison, Jolibois, Julia, Marquet de Rougé, Perrine, Nivet-Antoine, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914816/ https://www.ncbi.nlm.nih.gov/pubmed/33567593 http://dx.doi.org/10.3390/ijms22041693

Ejemplares similares

TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
por: Alhawiti, Naif Mohammad, et al.
Publicado: (2017)

TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook
por: Pan, Min, et al.
Publicado: (2022)

TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target
por: Choi, Eui-Hwan, et al.
Publicado: (2023)

Upregulation of miR-20b Protects Against Cerebral Ischemic Stroke by Targeting Thioredoxin Interacting Protein (TXNIP)
por: Yang, Dejiang, et al.
Publicado: (2021)

N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding
por: Cheng, Fengyu, et al.
Publicado: (2022)

TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
por: Borowiec, Agnieszka Magdalena, et al.
Publicado: (2022)

ODP251 Thioredoxin-Interacting Protein (Txnip) And Cellular Senescence: Potential Adverse Effects of Txnip Deficiency.
por: Abubaker, Mohammed, et al.
Publicado: (2022)

TXNIP Regulates Peripheral Glucose Metabolism in Humans
por: Parikh, Hemang, et al.
Publicado: (2007)

Signaling Pathway of Taurine-Induced Upregulation of TXNIP
por: Satsu, Hideo, et al.
Publicado: (2022)

RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
por: Sbai, Oualid, et al.
Publicado: (2022)

FOXC1: an emerging marker and therapeutic target for cancer
por: Han, Bingchen, et al.
Publicado: (2017)

RUNX1: an emerging therapeutic target for cardiovascular disease
por: Riddell, Alexandra, et al.
Publicado: (2020)

Identification of Redox and Glucose-Dependent Txnip Protein Interactions
por: Forred, Benjamin J., et al.
Publicado: (2016)

Correction to: RAGE-TXNIP axis drives inflammation in Alzheimer’s by targeting Aβ to mitochondria in microglia
por: Sbai, Oualid, et al.
Publicado: (2022)

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer
por: Morrison, Jennifer A, et al.
Publicado: (2014)

New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
por: Ding, Chunchun, et al.
Publicado: (2016)

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?
por: Bu, Zhong-Qi, et al.
Publicado: (2021)

Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014)

Induction of the Metabolic Regulator Txnip in Fasting-Induced and Natural Torpor
por: Hand, Laura E., et al.
Publicado: (2013)

Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction
por: Yang, Chun, et al.
Publicado: (2019)

TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
por: Yoshihara, Eiji
Publicado: (2020)

Oxidative stress-mediated TXNIP loss causes RPE dysfunction
por: Ji Cho, Min, et al.
Publicado: (2019)

Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
por: Tsubaki, Haruka, et al.
Publicado: (2020)

The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction
por: Locatelli, Laura, et al.
Publicado: (2023)

A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis
por: Guo, Qian, et al.
Publicado: (2023)

Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA
por: Chen, Julia Ling-Yu, et al.
Publicado: (2010)

The implications of exosomes in pregnancy: emerging as new diagnostic markers and therapeutics targets
por: Ghafourian, Mehri, et al.
Publicado: (2022)

Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy
por: Perrone, L, et al.
Publicado: (2010)

TXNIP shuttling: missing link between oxidative stress and inflammasome activation
por: Lane, Troy, et al.
Publicado: (2013)

Cutting Calories and TXNIP From the Skeletal Muscle to Restore Insulin Sensitivity
por: Anderson, Ethan J.
Publicado: (2016)

A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis
por: Zervou, Sevasti, et al.
Publicado: (2013)

Estradiol Regulates Txnip and Prevents Intermittent Hypoxia-Induced Vascular Injury
por: Lan, Xiao Fei, et al.
Publicado: (2017)

Glucose-6-Phosphate Upregulates Txnip Expression by Interacting With MondoA
por: Zhang, Xueyun, et al.
Publicado: (2020)

TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis
por: Woo, Sang-Ho, et al.
Publicado: (2022)

High TXNIP expression accelerates the migration and invasion of the GDM placenta trophoblast
por: Sa, Rina, et al.
Publicado: (2023)

Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP
por: Zhang, Caiyan, et al.
Publicado: (2018)

PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis
por: Li, Yu-Hang, et al.
Publicado: (2020)

Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
por: Taskinen, Marja-Riitta, et al.
Publicado: (2016)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

A novel TXNIP-based mechanism for Cx43-mediated regulation of oxidative drug injury
por: Gao, Kun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oh5t6akjd0vir5ohn996rjveub